Let us correct the most persistent myths
Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
Others: Roche, J&J, Sanofi, and AZ have had GLP-1 efforts (some deprioritized) or new dual/triple agonists in development (e.g., Roches pipeline includes a dual agonist announced in 2024)
Enter the Gila monster, a lizard native to the southern United States
The patches reduced body weight in the animal model by suppressing appetite and enhancing metabolic rate (8)
There are many theories about why some people fall into this category: Those with lower starting BMIs lose less weight